abs65.txt	chemo-immunotherapy	represents	an	appealing	approach	to	improving	cancertreatment		simultaneously	administrating	chemotherapeutics	with	immunoadjuvantscan	elicit	potent	tumor	death	and	immune	responses	herein	high	densitylipoprotein	(hdl)	inspired	lipoprotein	was	proposed	for	relay	drugdelivery	amplifying	antitumor	therapy	lipophilic	as1411aptamer-immunoadjuvant	cpg	fused	sequences	(apt-cpg-dspe)	were	conjugated	tofacilitate	decoration	onto	hdls	doxorubicin	(dox)	successivelyintercalated	into	the	consecutive	base	pairs	of	apt-cpg	complete	hdlnanodrug	imhdl/apt-cpg-dox	drug	delivery	underwentsite-specific	structure	collapse	in	intercellular	substances	fromhdl	biofunctions	(sequential	module	i)	subsequently	dissociated	apt-cpg-dox	wasendocytosed	cells	mediated	by	recognition	as1411	nucleolin(sequential	ii)	translocating	dox	nucleus	enabling	ablationand	antigens	release	liberated	motif	further	evoked	antigen	induced	vast	secretion	pro-inflammatory	cytokines	potentiated	hostantitumor	immunity	our	studies	demonstrated	that	hdl	biomimetic	platform	basedrelay	strategy	outperformed	monotherapy	counterparts	inmalignant	models	eventually	generating	augmented	efficacy
